Kantonsspital St.Gallen
login

projects

recently published research projects
SAKK 15/19 Thoracic radiotherapy plus maintenance...
2021-06-28
Standard of care for Extensive-Stage Disease (ED) Small Cell Lung Cancer (SCLC) as first-line treatment is 4 to 6 cycles of platinum based chemotherapy (carboplatin or cisplatin) in combination with etoposide. However, the outcome of the disease remains poor with a median overall survival of approximately 10 months, mainly caused by rapid ...
Assessing a ctDNA and PET-oriented therapy in patients...
2021-06-14
Despite advances in the clinical care of patients with DLBCL and in understanding the biology of this disease, cure rates have remained the same since the introduction of rituximab to CHOP chemotherapy, and RCHOP chemoimmunotherapy remains the standard of care. Over the last years many phase III trials investigating new agents added to R-CHOP have ...
SAKK 67/20 Open-label single-stage phase 1B study of the...
2021-06-09
Background: Docetaxel, a semi-synthetic analogue of paclitaxel, is one of the most widely used human anti-cancer agents. Docetaxel and paclitaxel belong to a group of cytotoxic agents called tax-anes. Docetaxel has been marketed worldwide by Sanofi-Aventis under the trade name Taxotere® and its use is ap-proved for different types of solid ...
other recently published research projects
number of projects
number of ongoing projects